This bidirectional effect, with overactivation driving vascular remodeling and deficiency leading to emphysematous destruction, supports HIF-2α as a molecular “switch” between vascular-dominant and airway/emphysema-dominant trajectories in COPD [110]. This evidence concerns the gene EPAS1 and pulmonary emphysema.